文献速递肝胆胰外科围术期管理与 ERAS

保留肝实质的肝切除术治疗累及肝腔静脉汇合部肿瘤的技术

Techniques of parenchyma-sparing hepatectomy for the treatment of tumors involving the hepatocaval confluence: A reliable way to assure an adequate future liver remnant volume.
PubMed 文献 · Surgery · 2017-05-24

该研究分析54例患者共60次保留肝实质的肝切除术,用于治疗累及肝腔静脉汇合部的7个原发和53个转移性肿瘤(48个结直肠转移)。所有病例均按术前影像规划完成保留肝实质的肝切除术,仅1例需切除3个相邻肝段;27%病例行肝静脉切除并采用多种血管干预保证流出道,25%行切向切除直接缝合,48%从肿瘤上骨骼化肝静脉。IIIb-IV级并发症发生率为7%,中位住院9天,90天死亡1例(肝硬化患者)。

要点

  • 保留肝实质的肝切除术可用于累及肝腔静脉汇合部的肿瘤,仅1例需切除3个相邻肝段。
  • 肝静脉切除后可通过保留肝右 inferior 静脉、交通静脉、肝中静脉、聚四氟乙烯人工血管或肝静脉吻合等方式保证流出道。
  • IIIb-IV级并发症发生率为7%,中位住院9天,90天死亡1例肝硬化患者。

核心结论

  • 对于累及肝腔静脉汇合部的肿瘤,采用保留肝实质的肝切除术而非规则性大范围肝切除术,可完成手术且主要并发症发生率低(7%)。
  • 基于适当且准确的术前影像,在严格选择的患者中应考虑保留肝实质的肝切除术。

研究设计与样本

  • 回顾性分析54例患者连续60次保留肝实质的肝切除术,肿瘤位于I、VII、VIII或IVa段并累及肝腔静脉汇合部。
  • 肿瘤包括7个原发肿瘤和53个转移性肿瘤(其中48个为结直肠转移);患者中位病灶数2个(范围1-18),中位直径4 cm(范围1.2-16.5),43%为双侧。

主要发现

  • 60次手术均完成保留肝实质的肝切除术,仅1例需切除3个相邻肝段。
  • 16例(27%)行肝静脉切除,流出道通过保留肝右下静脉3例(5%)、保留交通静脉4例(7%)、保留肝中静脉3例(4%;其中2例行肝中静脉补片重建)、聚四氟乙烯人工血管4例(7%)及肝静脉吻合2例(3%)来保证。
  • 15例(25%)行肝静脉切向切除并直接缝合静脉修补,29例(48%)将肝静脉从肿瘤上骨骼化。
  • IIIb-IV级并发症发生率为7%,中位住院时间9天,90天死亡1例(肝硬化患者)。
  • 中位总生存期和无病生存期分别为72个月和16个月(中位随访34个月)。

临床怎么用

  • 在评估累及肝腔静脉汇合部肿瘤的肝切除时,基于适当且准确的术前影像,对严格选择的患者可考虑保留肝实质的肝切除术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Parenchyma-sparing hepatectomy techniques allow a lesser volume resection (<3 adjacent segments) for tumors involving the hepatic veins at the hepatocaval confluence, assuring adequate volume of the future liver remnant. We report the ability to perform parenchyma-sparing hepatectomy as planned from the preoperative imaging and the type of vascular intervention used to preserve hepatic outflow. METHODS: We analyzed 60 consecutive parenchyma-sparing hepatectomies in 54 patients for 7 primary and 53 metastatic tumors (48 colorectal), located in segments I, VII, VIII, or IVa and involving the hepatocaval confluence. Patients had a median of 2 (range: 1-18) lesions with median diameter of 4 cm (range: 1.2-16.5), which were bilateral in 43%. RESULTS: A parenchyma-sparing hepatectomy was performed in all of the 60 cases, only one case required the resection of 3 adjacent segments. In 16 (27%) hepatic veins-resections, the outflow was assured by preservation of the inferior-right-hepatic veins in 3 (5%), of the communicating-veins in 4 (7%), of the middle-hepatic veins in 3 (4%; middle-hepatic veins patch-reconstruction in 2 cases), by polytetrafluoroethylene-grafts in 4 (7%), and by hepatic veins-anastomosis in 2 (3%). In 15 (25%) cases, the hepatic veins were resected tangentially and reconstructed by direct suture venorraphy. In 29 (48%) cases, the hepatic veins were skeletonized from the tumor. Grade IIIb to IV complications occurred in 7%, median hospital-stay was 9 days, and 90-day mortality occurred in one cirrhotic patient. Median overall and disease-free survivals were 72 and 16 months (median follow-up: 34 months). CONCLUSION: A lesser volume parenchyma-sparing hepatectomy rather than a formal major hepatectomy for tumors involving the hepatocaval confluence can be performed with a low rate of major complications (7%). Parenchyma-sparing hepatectomy should be considered in highly selected patients when evaluating liver resection for tumors involving the hepatocaval confluence based on appropriate and accurate preoperative imaging.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Urbani L, Colombatto P, Balestri R, et al. Techniques of parenchyma-sparing hepatectomy for the treatment of tumors involving the hepatocaval confluence: A reliable way to assure an adequate future liver remnant volume. Surgery. 2017. PMID: 28549521. doi:10.1016/j.surg.2017.02.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。